MDT Medtronic plc

Price (delayed)

$91.38

Market cap

$121.42B

P/E Ratio

24.37

Dividend/share

$2.57

EPS

$3.75

Enterprise value

$141.82B

Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around ...

Highlights
The net income has grown by 40% YoY and by 2.5% from the previous quarter
The EPS rose by 40% year-on-year and by 2.7% since the previous quarter
Medtronic's quick ratio has decreased by 32% YoY and by 30% from the previous quarter

Key stats

What are the main financial stats of MDT
Market
Shares outstanding
1.33B
Market cap
$121.42B
Enterprise value
$141.82B
Valuations
Price to earnings (P/E)
24.37
Price to book (P/B)
2.33
Price to sales (P/S)
3.87
EV/EBIT
23.45
EV/EBITDA
16.2
EV/Sales
4.48
Earnings
Revenue
$31.69B
EBIT
$6.05B
EBITDA
$8.76B
Free cash flow
$5.98B
Per share
EPS
$3.75
Free cash flow per share
$4.45
Book value per share
$39.17
Revenue per share
$23.6
TBVPS
$25.99
Balance sheet
Total assets
$90.98B
Total liabilities
$38.26B
Debt
$24.11B
Equity
$52.55B
Working capital
$10.67B
Liquidity
Debt to equity
0.46
Current ratio
1.86
Quick ratio
1.3
Net debt/EBITDA
2.33
Margins
EBITDA margin
27.6%
Gross margin
68%
Net margin
15.9%
Operating margin
18.2%
Efficiency
Return on assets
5.5%
Return on equity
9.7%
Return on invested capital
12.9%
Return on capital employed
7.7%
Return on sales
19.1%
Dividend
Dividend yield
2.81%
DPS
$2.57
Payout ratio
68.5%

MDT stock price

How has the Medtronic stock price performed over time
Intraday
1.82%
1 week
1.29%
1 month
-6.55%
1 year
-27.55%
YTD
-11.67%
QTD
1.82%

Financial performance

How have Medtronic's revenue and profit performed over time
Revenue
$31.69B
Gross profit
$21.54B
Operating income
$5.75B
Net income
$5.04B
Gross margin
68%
Net margin
15.9%
The net income has grown by 40% YoY and by 2.5% from the previous quarter
MDT's net margin is up by 33% year-on-year and by 2.6% since the previous quarter
The operating income has increased by 28% YoY
The operating margin has increased by 22% year-on-year

Growth

What is Medtronic's growth rate over time

Valuation

What is Medtronic stock price valuation
P/E
24.37
P/B
2.33
P/S
3.87
EV/EBIT
23.45
EV/EBITDA
16.2
EV/Sales
4.48
The EPS rose by 40% year-on-year and by 2.7% since the previous quarter
The price to earnings (P/E) is 30% lower than the 5-year quarterly average of 34.6 and 28% lower than the last 4 quarters average of 34.0
The stock's price to book (P/B) is 22% less than its last 4 quarters average of 3.0 and 14% less than its 5-year quarterly average of 2.7
The company's equity rose by 2.2% YoY
MDT's P/S is 21% lower than its last 4 quarters average of 4.9 and 14% lower than its 5-year quarterly average of 4.5
Medtronic's revenue has increased by 5% YoY

Efficiency

How efficient is Medtronic business performance
MDT's return on assets is up by 45% year-on-year and by 3.8% since the previous quarter
Medtronic's return on equity has increased by 37% YoY and by 2.1% QoQ
The company's return on invested capital rose by 26% YoY and by 3.2% QoQ
The return on sales rose by 20% year-on-year

Dividends

What is MDT's dividend history
DPS
$2.57
Dividend yield
2.81%
Payout ratio
68.5%
Recent dividends

Financial health

How did Medtronic financials performed over time
The total assets is 138% greater than the total liabilities
Medtronic's quick ratio has decreased by 32% YoY and by 30% from the previous quarter
The company's current ratio fell by 30% YoY and by 29% QoQ
MDT's debt is 54% smaller than its equity
Medtronic's debt to equity has decreased by 10% YoY and by 4.2% from the previous quarter
MDT's debt is down by 9% year-on-year and by 4.1% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.